Paul Peter Tak, M.D., Ph.D., FMedSci

Overview

Paul Peter Tak, M.D., Ph.D., FMedSci received an average of $2M in total compensation, including $505K in salary, at Candel Therapeutics from 2020 to 2023.

Related executives

We found five more executives who work or worked at Candel Therapeutics.

News

Candel Therapeutics CEO Paul FMedSci's 2023 pay slips 20% to $1.5M

May 30, 2024

---

Candel Therapeutics CEO Paul FMedSci's 2022 pay jumps 93% to $1.8M

May 23, 2023

---

Candel Therapeutics CEO Paul FMedSci's 2021 pay falls 64% to $957K

September 2, 2022

---

You may also like